The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
Everett Meyer
BMT specialist, Hematologist
Practice Areas
Professional Education
- Fellowship: gotStanford University - Hematology and Oncology (2013) CA
- Residency: Stanford University Hospital -Clinical Excellence Research Center (2010) CA
- Internship: Stanford University Hospital -Clinical Excellence Research Center (2009) CA
- Medical Education: Stanford University (2008) CA
- Board Certification: Internal Medicine, American Board of Internal Medicine (2011)
Honors & Awards
- Young Investigator Award, American Society of Blood and Marrow Transplantation (2011)
- Amy Streizer Manasevit Scholar, National Donor Marrow Program and American Society for Blood and Marrow Transplantation (2013)
- Beckman Center Technology Grant, Stanford University (2014)
Publications
-
Third-party CD4(+) invariant natural killer T cells protect from murine GVHD lethality
Schneidawind, D., Baker, J., Pierini, A., Buechele, C., Luong, R. H., & Negrin, R. S. (2015). Third-party CD4(+) invariant natural killer T cells protect from murine GVHD lethality. BLOOD, 125(22), 3491-3500. -
CD4(+) invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4(+)CD25(+)FoxP3(+) regulatory T cells
Schneidawind, D., Pierini, A., Alvarez, M., Pan, Y., Baker, J., & Negrin, R. S. (2014). CD4(+) invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4(+)CD25(+)FoxP3(+) regulatory T cells. BLOOD, 124(22), 3320-3328. -
Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models
Florek, M., Sega, E. I., Leveson-Gower, D. B., Baker, J., Mueller, A. Ms., & Negrin, R. S. (2014). Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models. BLOOD, 124(11), 1832-1842. -
Memory regulatory T cells reside in human skin
Rodriguez, R. S., Pauli, M. L., Neuhaus, I. M., Yu, S. S., Arron, S. T., & Rosenblum, M. D. (2014). Memory regulatory T cells reside in human skin. JOURNAL OF CLINICAL INVESTIGATION, 124(3), 1027-1036.
-
Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance.
de Almeida, P. E., Meyer, E. H., Kooreman, N. G., Diecke, S., Dey, D., & Wu, J. C. (2014). Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nature communications, 5, 3903-?.
-
Prevalence of graft versus host disease and cytomegalovirus infection in patients post-haematopoietic cell transplantation presenting with gastrointestinal symptoms.
Liu, A., Meyer, E., Johnston, L., Brown, J., & Gerson, L. B. (2013). Prevalence of graft versus host disease and cytomegalovirus infection in patients post-haematopoietic cell transplantation presenting with gastrointestinal symptoms. Alimentary pharmacology & therapeutics, 38(8), 955-966.
-
A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease
Meyer, E. H., Hsu, A. R., Liliental, J., Loehr, A., Florek, M., & Negrin, R. S. (2013). A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease. BLOOD, 121(24), 4955-4962.
-
Apoptotic Cells Activate NKT Cells through T Cell Ig-Like Mucin-Like-1 Resulting in Airway Hyperreactivity
Lee, H.-H., Meyer, E. H., Goya, S., Pichavant, M., Kim, H. Y., & Umetsu, D. T. (2010). Apoptotic Cells Activate NKT Cells through T Cell Ig-Like Mucin-Like-1 Resulting in Airway Hyperreactivity. JOURNAL OF IMMUNOLOGY, 185(9), 5225-5235.
-
Activation of nonclassical CD1d-restricted NK T cells induces airway hyperreactivity in beta(2)-microglobulin-deficient mice
Koh, Y. I., Kim, H. Y., Meyer, E. H., Pichavant, M., Akbari, O., & Umetsu, D. T. (2008). Activation of nonclassical CD1d-restricted NK T cells induces airway hyperreactivity in beta(2)-microglobulin-deficient mice. JOURNAL OF IMMUNOLOGY, 181(7), 4560-4569.
-
ICOS/ICOSL interaction is required for CD4(+) invariant NKT cell function and homeostatic survival
Akbari, O., Stock, P., Meyer, E. H., Freeman, G. J., Sharpe, A. H., & DeKruyff, R. H. (2008). ICOS/ICOSL interaction is required for CD4(+) invariant NKT cell function and homeostatic survival. JOURNAL OF IMMUNOLOGY, 180(8), 5448-5456.
-
Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17
Pichavant, M., Goya, S., Meyer, E. H., Johnston, R. A., Kim, H. Y., & Umetsu, D. T. (2008). Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. JOURNAL OF EXPERIMENTAL MEDICINE, 205(2), 385-393.
-
T cells and NKT cells in the pathogenesis of asthma
Meyer, E. H., DeKruyff, R. H., & Umetsu, D. T. (2008). T cells and NKT cells in the pathogenesis of asthma. ANNUAL REVIEW OF MEDICINE, 59, 281-292.
-
Delirium following abrupt discontinuation of fluoxetine
Blum, D., Maldonado, J., Meyer, E., & Lansberg, M. (2008). Delirium following abrupt discontinuation of fluoxetine. CLINICAL NEUROLOGY AND NEUROSURGERY, 110(1), 69-70.
-
Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17
Pichavant, M., Goya, S., Meyer, E., Johnston, R., Kim, H., & Umetsu, D. (2008). Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. CLINICAL IMMUNOLOGY, 127, S38-S38.
-
INKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity
Meyer, E. H., Wurbel, M.-A., Staton, T. L., Pichavant, M., Kan, M. J., & Umetsu, D. T. (2007). INKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. JOURNAL OF IMMUNOLOGY, 179(7), 4661-4671.
-
iNKT cells in allergic disease
Meyer, E. H., DeKruyff, R. H., & Umetsu, D. T. (2007). iNKT cells in allergic disease. T CELL ACTIVATION BY CD1 AND LIPID ANTIGENS, 314, 269-291.
-
Natural killer T cells regulate the development of asthma
Umetsu, D. T., Meyer, E. H., & DeKruyff, R. H. (2007). Natural killer T cells regulate the development of asthma. INTERNATIONAL REVIEWS OF IMMUNOLOGY, 26(1-2), 121-140.
-
CD1d restricted natural killer T cells are not required for allergic skin inflammation
Elkhal, A., Pichavant, M., He, R., Scott, J., Meyer, E., & Umetsu, D. T. (2006). CD1d restricted natural killer T cells are not required for allergic skin inflammation. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 118(6), 1363-1368.
-
Medicine on a need-to-know basis
Busch, R., Byrne, B., Gandrud, L., Sears, D., Meyer, E., & Mellins, E. D. (2006). Medicine on a need-to-know basis. NATURE IMMUNOLOGY, 7(6), 543-547.
-
Glycolipid activation of invariant T cell receptor(+) NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4(+) T cells
Meyer, E. H., Goya, S., Akbari, O., Berry, G. J., Savage, P. B., & Umetsu, D. T. (2006). Glycolipid activation of invariant T cell receptor(+) NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4(+) T cells. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 103(8), 2782-2787.
-
iNKT-Cells require CCR4 binding of CCL17 to localize to the airways where they are necessary and sufficient for inducing airway hyperreactivity.
Meyer, E., Wurbel, M.-A., Staton, T., Savage, P., DeKruyff, R., & Umetsu, D. (2006). iNKT-Cells require CCR4 binding of CCL17 to localize to the airways where they are necessary and sufficient for inducing airway hyperreactivity. CLINICAL IMMUNOLOGY, 119, S22-S22.
-
Glycolipid mediated activation of iNKT cells is sufficient to induce airway hyperreactivity independent of conventional CD4 T cells.
Meyer, E. H., Akbari, O., Berry, G., Savage, P., DeKruyff, R. H., & Umetsu, D. T. (2005). Glycolipid mediated activation of iNKT cells is sufficient to induce airway hyperreactivity independent of conventional CD4 T cells. CLINICAL IMMUNOLOGY, 115, S14-S15.
-
Adaptation at specific loci. VII. Natural selection, dispersal and the diversity of molecular-functional variation patterns among butterfly species complexes (Colias : Lepidoptera, Pieridae)
Watt, W. B., Wheat, C. W., Meyer, E. H., & Martin, J. F. (2003). Adaptation at specific loci. VII. Natural selection, dispersal and the diversity of molecular-functional variation patterns among butterfly species complexes (Colias : Lepidoptera, Pieridae). MOLECULAR ECOLOGY, 12(5), 1265-1275.
-
Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity
Akbari, O., Stock, P., Meyer, E., Kronenberg, M., Sidobre, S., & Umetsu, D. T. (2003). Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. NATURE MEDICINE, 9(5), 582-588.
-
CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation
Oh, J. W., Seroogy, C. M., Meyer, E. H., Akbari, O., Berry, G., & Umetsu, D. T. (2002). CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 110(3), 460-468.
-
Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity
Akbari, O., Freeman, G. J., Meyer, E. H., Greenfield, E. A., Chang, T. T., & Umetsu, D. T. (2002). Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. NATURE MEDICINE, 8(9), 1024-1032.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Aug 2015
Dr. Meyer and his fellow were great & answered ALL of my ?'s.
SHC Patient, Jan 2015
I could not ask for a better physicians (Meyer) medical staff, nursing (Zoe), social worker (Morgan Cross) than this group!
SHC Patient, Dec 2014
Dr. Meyer is one of the best doctors I have every seen.
SHC Patient, Aug 2015
Dr. Meyer and his fellow were great & answered ALL of my ?'s.
SHC Patient, Jan 2015
I could not ask for a better physicians (Meyer) medical staff, nursing (Zoe), social worker (Morgan Cross) than this group!
SHC Patient, Dec 2014
Dr. Meyer is one of the best doctors I have every seen.